Trader consensus on Polymarket heavily favors a cumulative U.S. influenza hospitalization rate of 85–90 per 100,000 population for Week 16 (April 19–25, 2026), reflecting the CDC FluView Week 15 report showing 85.2 per 100,000—the third highest cumulative since 2010–2011—after a modest weekly increase of 0.7 from Week 14's 84.5. Declining seasonal activity drives this positioning, with Week 15's weekly rate dropping to 0.5 per 100,000 amid very low outpatient respiratory illness visits (1.9%, below baseline) and low emergency department encounters nationwide. FluSurv-NET data indicate influenza A(H3N2) dominance but overall downward trends, though reporting delays suggest the adjusted Week 15 weekly rate could reach 0.7–0.9 per 100,000. Week 16 FluView, expected soon, may refine this with preliminary data amid minimal transmission.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedFlu Hospitalization Rate Week 16, 2026?
Flu Hospitalization Rate Week 16, 2026?
85–90 79.3%
80–85 3.1%
90–95 2.7%
100+ 1.4%
<80
1%
80–85
3%
85–90
79%
90–95
3%
95–100
1%
100+
1%
85–90 79.3%
80–85 3.1%
90–95 2.7%
100+ 1.4%
<80
1%
80–85
3%
85–90
79%
90–95
3%
95–100
1%
100+
1%
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Market Opened: Apr 24, 2026, 11:18 AM ET
Resolver
0x69c47De9D...If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Resolver
0x69c47De9D...Trader consensus on Polymarket heavily favors a cumulative U.S. influenza hospitalization rate of 85–90 per 100,000 population for Week 16 (April 19–25, 2026), reflecting the CDC FluView Week 15 report showing 85.2 per 100,000—the third highest cumulative since 2010–2011—after a modest weekly increase of 0.7 from Week 14's 84.5. Declining seasonal activity drives this positioning, with Week 15's weekly rate dropping to 0.5 per 100,000 amid very low outpatient respiratory illness visits (1.9%, below baseline) and low emergency department encounters nationwide. FluSurv-NET data indicate influenza A(H3N2) dominance but overall downward trends, though reporting delays suggest the adjusted Week 15 weekly rate could reach 0.7–0.9 per 100,000. Week 16 FluView, expected soon, may refine this with preliminary data amid minimal transmission.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions